Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
Hossein Taghizadeh(Comprehensive Cancer Center Vienna), Gerald W. Prager(Comprehensive Cancer Center Vienna)
Cited by 6
Related Papers
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
|New England Journal of Medicine|2023|415
Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
|Blood|2008|60
Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma
|Thoracic Cancer|2020|4
Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients
|Frontiers in Oncology|2023|1